AEON
AEON Biopharma, Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
AEON Biopharma, Inc.
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
No changes.
No changes.
AEON Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on developing botulinum toxins. It develops ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, which completed a Phase 2 study for the treatment of cervical dystonia and has an ongoing Phase 2 study for the treatment of both chronic and episodic migraine. AEON Biopharma, Inc. is based in Irvine, California.
AEON Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on developing botulinum toxins. It develops ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, which completed a Phase 2 study for the treatment of cervical dystonia and has an ongoing Phase 2 study for the treatment of both chronic and episodic migraine. AEON Biopharma, Inc. is based in Irvine, California.
Annual filing, covered
10-K parsed · Mar 30 '26
Supply-chain ties, covered
Disclosed · both directions
Fund holders, covered
No N-PORT holders
13F holdings, covered
13F quarter · Jun 30 '26
Management, not covered
Not covered · DEF 14A, 8-K 5.02
Company IR feed, not covered
News via newswires & EDGAR
Products, patents, hiring, not covered
Not covered
Annual filing, covered
10-K parsed · Mar 30 '26
Supply-chain ties, covered
Disclosed · both directions
Fund holders, covered
No N-PORT holders
13F holdings, covered
13F quarter · Jun 30 '26
Management, not covered
Not covered · DEF 14A, 8-K 5.02
Company IR feed, not covered
News via newswires & EDGAR
Products, patents, hiring, not covered
Not covered
No thesis.
—
AEON Biopharma, Inc.
0.27
Tall tick = annual report · Source: EDGAR
—
Largest filed tie
—
No peers for AEON Biopharma, Inc. yet.
No peers for AEON Biopharma, Inc. yet.
Expected move
No implied move.
—
—
| Manager | Value | % base | |
|---|---|---|---|
| Dauntless Investment | $9.0M | 97.55% | +394.12% |
| Geodeindex-like | $68,556 | 0.74% | +9.47% |
| Vanguardindex-like | $65,090 | 0.71% | 0.00% |
| Blue Owl Capital | $30,494 | 0.33% | 0.00% |
| Intl Fcstone | $14,942 | 0.16% | new |
| Manager | Value | % base | |
|---|---|---|---|
| Dauntless Investment | $9.0M | 97.55% | +394.12% |
| Geodeindex-like | $68,556 | 0.74% | +9.47% |
| Vanguardindex-like | $65,090 | 0.71% | 0.00% |
| Blue Owl Capital | $30,494 | 0.33% | 0.00% |
| Intl Fcstone | $14,942 | 0.16% | new |
+358.04%
shares held · 10 largest managers